Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Quarterly results
Appointed director
CC transcript
Auditor change
Director departure
|
|
JUNIPER PHARMACEUTICALS INC (JNP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/27/2018 |
GN
| Gainey McKenna & Egleston Announces that Class Action Lawsuit Has Been Filed Against Juniper Pharmaceuticals, Inc. (JNP) And Its Directors |
| 07/11/2018 |
GN
| MERGER ALERT -- WEB, EDR, JNP: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies |
| 07/11/2018 |
GN
| MERGER ALERT -- WEB, EDR, JNP: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies |
| 07/06/2018 |
GN
| INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Juniper Pharmaceuticals, Inc. to Catalent Inc. is Fair to Shareholders |
| 07/06/2018 |
GN
| Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Juniper Pharmaceuticals, Inc. (JNP) on Behalf of Stockholders and Encourages Investors to Contact the Firm |
| 05/30/2017 |
GN
| George O. Elston Named Chief Executive Officer of 2X Oncology |
|
|